Edwin Hardeman (R), with his attorneys Jennifer Moore (L) and Aimee Wagstaff, speaks to the media, after Bayer AG was found liable for Hardeman’s non-Hodgkin’s lymphoma arising from his use of the company’s weed killer Roundup, at the Federal court in San Francisco, California, U.S., March 27, 2019. REUTERS/Alexandria Sage
SAN FRANCISCO/NEW YORK (Reuters) - A U.S. jury on Wednesday awarded $80 million (£60.5 million) to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.
The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman's non-Hodgkin's lymphoma.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
